David J. Greenblatt - Nanotechnology

Author Information

David J. Greenblatt is a prominent researcher affiliated with the Program in Pharmacology and Experimental Therapeutics at Tufts University School of Medicine in Boston, MA, USA. His extensive research primarily focuses on pharmacokinetics, drug interactions, and therapeutic strategies for various conditions.

Research Contributions

David J. Greenblatt has made significant contributions to the field of pharmacology, as evidenced by his numerous publications. His research has explored critical areas such as drug interactions, the pharmacokinetics of various medications, and the impact of obesity on drug distribution and elimination. Notably, his recent work includes studies on the interactions of Nirmatrelvir and Ritonavir, the pharmacokinetics of Brexpiprazole, and therapeutic strategies for SOD1-related ALS. His contributions have provided valuable insights into optimizing drug efficacy and safety.

Aliases

David J. Greenblatt has been cited under various aliases, including Davidj Greenblatt, Davidj. Greenblatt, David Greenblatt, D J. Greenblatt, D Greenblatt, D. Greenblatt, David J. Greenblatt, D.j. Greenblatt, and D J Greenblatt.

Publication and Citation Metrics

Metric Value
Citation Count 61,110
h-index 113
Paper Count 1,297

Publications:

DOI: 10.1002/cpdd.900

Year: 2021

DOI:

Year: 2020

DOI: 10.1007/s40263-020-00772-y

Year: 2020

Partnered Content Networks

Relevant Topics